Cargando…
Testosterone replacement in the infertile man
Hypogonadism is a common clinical condition affecting men of different age groups. In addition to its sexual consequences, it has several implications posing significant concerns for a man’s health and well-being. Recent advances in testosterone (T) supplementation have facilitated hypogonadism trea...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182223/ https://www.ncbi.nlm.nih.gov/pubmed/28078217 http://dx.doi.org/10.21037/tau.2016.08.03 |
_version_ | 1782485827198124032 |
---|---|
author | Majzoub, Ahmad Sabanegh, Edmund |
author_facet | Majzoub, Ahmad Sabanegh, Edmund |
author_sort | Majzoub, Ahmad |
collection | PubMed |
description | Hypogonadism is a common clinical condition affecting men of different age groups. In addition to its sexual consequences, it has several implications posing significant concerns for a man’s health and well-being. Recent advances in testosterone (T) supplementation have facilitated hypogonadism treatment. Despite that, patients complaining of infertility or seeking conception are still hindered by the unfavorable effects supplemental T has on testicular function. Consequently, alternative approaches that can stimulate endogenous T production are favored. Selective estrogen receptor modulators, gonadotropins and aromatase inhibitors (AIs) can be successful in restoring serum T levels, preserving fertility, and providing symptomatic relief. |
format | Online Article Text |
id | pubmed-5182223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-51822232017-01-11 Testosterone replacement in the infertile man Majzoub, Ahmad Sabanegh, Edmund Transl Androl Urol Review Article Hypogonadism is a common clinical condition affecting men of different age groups. In addition to its sexual consequences, it has several implications posing significant concerns for a man’s health and well-being. Recent advances in testosterone (T) supplementation have facilitated hypogonadism treatment. Despite that, patients complaining of infertility or seeking conception are still hindered by the unfavorable effects supplemental T has on testicular function. Consequently, alternative approaches that can stimulate endogenous T production are favored. Selective estrogen receptor modulators, gonadotropins and aromatase inhibitors (AIs) can be successful in restoring serum T levels, preserving fertility, and providing symptomatic relief. AME Publishing Company 2016-12 /pmc/articles/PMC5182223/ /pubmed/28078217 http://dx.doi.org/10.21037/tau.2016.08.03 Text en 2016 Translational Andrology and Urology. All rights reserved. |
spellingShingle | Review Article Majzoub, Ahmad Sabanegh, Edmund Testosterone replacement in the infertile man |
title | Testosterone replacement in the infertile man |
title_full | Testosterone replacement in the infertile man |
title_fullStr | Testosterone replacement in the infertile man |
title_full_unstemmed | Testosterone replacement in the infertile man |
title_short | Testosterone replacement in the infertile man |
title_sort | testosterone replacement in the infertile man |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182223/ https://www.ncbi.nlm.nih.gov/pubmed/28078217 http://dx.doi.org/10.21037/tau.2016.08.03 |
work_keys_str_mv | AT majzoubahmad testosteronereplacementintheinfertileman AT sabaneghedmund testosteronereplacementintheinfertileman |